Business

June 17, 2014

FDA approves Novartis vaccine plant in Holly Springs

Federal regulators have issued approval for a five-year-old vaccine plant in Holly Springs that Swiss drugmaker Novartis said will be the first U.S. facility to make commercial supplies of flu vaccine from cell cultures instead of chicken eggs.

Related content

Comments

Editor's Choice Videos